Sinocare Showcases Integrated Diabetes Management Solutions at ATTD-Asia 2025

From December 9 to 11, 2025, the 2nd Advanced Technologies & Treatments for Diabetes Asia Conference (ATTD-Asia 2025) concluded successfully in Singapore. Focusing on breakthrough innovations in diabetes management technologies and therapeutic strategies, the conference brought together leading experts from around the world. It highlighted Asia’s advancing practices in diabetes care while fostering critical dialogue and collaboration to address the global diabetes challenge.

As the leading diabetes digital management expert in the world, Sinocare presented a range of innovative products at the conference and hosted a dedicated symposium, engaging with global peers to explore emerging opportunities and challenges in diabetes management.

Products: The Key to Solving Real-World Problems

At the exhibition, Sinocare systematically demonstrated its end-to-end solutions for diabetes and chronic disease management—from home to hospital settings, from glucose monitoring to multi-parameter testing, and from measurement to comprehensive management—attracting significant attention from conference participants.

01 Home-use Products

Addressing everyday chronic disease management needs, Sinocare showcased a portfolio of smart, user-friendly home monitoring devices, offering flexible options tailored to diverse user requirements.

Safe AQ Series Blood Glucose Meters – lightweight and portable

BA Series Blood Pressure Monitors – simple, reliable, and easy to use

UG Blood Glucose & Uric Acid Meter – dual-parameter testing

KUG-11 Glucose, Uric Acid & Ketone Meter – multi-parameter detection

H102 Air Hemoglobin Analyzer – convenient at-home anemia testing

Through continuous innovation in home-based monitoring devices, Sinocare is making daily health management simpler, more reliable, and more accessible.

02 Professional Hospital-Use Products

For clinical applications, Sinocare presented its high-performance professional product portfolio, designed to support efficiency and accuracy in medical settings.

iCARE1300 and PCH-50, forming a POCT solution that enables rapid, multi-parameter testing and improves clinical diagnostic efficiency

AGEScan, focusing on early screening of diabetes-related complications to support risk assessment and early intervention

CGM integrated with hospital management systems, enabling real-time, unified in-hospital glucose data management and supporting clinical decision-making

Ideas: The Engine Driving Transformation

Sinocare hosted a themed symposium titled “Practices and Perspectives on Digital and Personalized Diabetes Management.” The session was chaired by Dr. Manoj S. Chawla, a leading diabetologist from India, and brought together authoritative experts from multiple countries for in-depth discussions on CGM, in-hospital management systems, and pediatric and adolescent diabetes care.

Dr. Mikhailova, Head of the Department of Endocrinology at the Samara Regional Children’s Clinical Hospital (Russia), presented “Outcomes of CGM Use in Children and Adolescents in the Samara Region of the Russian Federation.” Based on regional clinical data, she detailed the effectiveness of CGM in pediatric diabetes management, improvements in glycemic control, and positive impacts on family quality of life—providing valuable evidence for refined management and remote monitoring in pediatric diabetes care.

Professor Gong Lilin, Chief Physician and Master’s Supervisor, Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, shared “Clinical Experience with the B+C+In-Hospital Integrated Management System.” Through real-world cases, she illustrated the system’s efficiency and safety in inpatient glucose monitoring, integration with insulin pump therapy, and multidisciplinary collaboration—offering a practical pathway for the digital upgrade of in-hospital diabetes management.

Professor Ji Qiuhe, President of the Endocrinology and Metabolism Hospital at Xi’an International Medical Center and Vice Chairman of the Chinese Diabetes Society, delivered an in-depth analysis titled “The Clinical Value of CGM.” From perspectives including clinical benefits, data interpretation, patient education, and long-term management, he explored how CGM supports individualized treatment decisions, improves glycemic variability, prevents complications, and outlined the future potential of CGM combined with artificial intelligence.

The symposium underscored that digitalization and personalization have become central trends in global diabetes management, further validating Sinocare’s value proposition of empowering full-cycle diabetes care through innovative technologies and integrated system solutions.

Looking ahead, Sinocare will continue to adopt an open and collaborative approach, deepen global partnerships, and advance technological integration—delivering more diverse and effective diabetes management solutions for patients and healthcare professionals worldwide.